Webinar and eBook Overview: Understanding the Path to Manufacturing Immunotherapies
This webinar and eBook uncover the latest techniques in cell and gene therapy treatments for immunotherapy to recognize, target, and eliminate cancer cells and tumors. Our cell therapy process development expert examines each type of leading cell therapy, from TILs to TCRs to CAR-T and NKs, as well as autologous and allogeneic options to better understand these evolving therapies.
In this webinar and eBook, you’ll learn:
- How to go from process to IND for an autologous CAR-T therapy in a matter of weeks.
- How to improve cell and gene therapy workflows for the top cell therapy immunotherapy treatments.
- Why qualifying the drug product early accelerates development and regulatory approvals later in the process.
Viewers will be taken through the measurements for success and best practices when designing an immunotherapy program.
Webinar Presenter
Alex Sargent
Director of Process Development, Cell and Gene Therapy